Analysts Raise The Roof With Boosted Price Targets For Builders Firstsource
Analysts are upbeat on the growth prospects of Builders FirstSource Inc (NYSE: BLDR) and raised the price target.
Analysts Say Eli Lilly’s Donanemab In Alzheimer’s Is Encouraging, Outline Potential Implications For Biogen
Wednesday, Eli Lilly And Co (NYSE: LLY) announced positive results of the TRAILBLAZER-ALZ 2 Phase 3 study of
Why Regeneron Pharmaceuticals Shares Are Trading Lower Today
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned adjusted EPS of $10.09, down 12% Y/Y, beating
Becton, Dickinson Shares Dip Despite Q2 Earnings Beat – Here’s The Deatils
Becton, Dickinson, and Company (NYSE: BDX) posted profits of $460 million, equivalent to $2.86 per share,
Magellan Midstream Misses Q1 Earnings Estimate, 2023 Guidance Raised On Improved Operations
Magellan Midstream Partners LP (NYSE: MMP) reported Q1 2023 revenues of $675 million, missing the consensus of $723.5 million.
Senate Committee Confronts Surge Of Bank Failures – Demands Swift Action, Stricter Regulations
The Senate Banking Committee on Thursday held a hearing on the recent spate of bank failures.
What Has Happened To The Unsold Adidas Yeezy Shoes? Analysts Expect 4% Q1 Revenue Decline
Adidas AG (NYSE: ADDYY) is expected to provide an update about the unsold Yeezy shoes when it reports Q1 2023 results tomorrow.
Kellogg Tightens FY23 Growth Outlook, But Optimistic As It Plans To Separate North America Cereal Business
Kellogg Company (NYSE:K) reported first-quarter FY23 sales growth of 10.4% year-on-year to $4.053 billion, beating the consensus of $3.95 billion.…
Novo Nordisk Clocks 27% Jump In Q1 Sales, Reduces Low-Dose Wegovy Supply To Manage Rising Demand
Novo Nordisk A/S (NYSE:NVO) reported Q1 FY23 sales of DKK 53.37 billion, up 27% Y/Y (+25% on constant currency). Earlier this…